Fig. 6: Seizure relapse forest plot comparing midazolam and diazepam.

Meta-analysis of the odds of seizure relapse with Midazolam versus Diazepam. The overall pooled analysis showed a statistically significant benefit for Midazolam, which was associated with a lower odds of seizure relapse (RR = 0.51; 95% (CI): [0.27, 0.98], p = 0.04). The analysis demonstrated no heterogeneity among the included studies (I2 = 0%).